Last updated: August 9, 2025
Introduction
Hong Kong Patent HK1083759 pertains to a novel pharmaceutical invention. As a specialized drug patent, understanding its scope, claims, and the broader patent landscape is crucial for stakeholders involved in drug development, licensing, and competitive intelligence. This analysis provides a comprehensive overview of the patent’s core features, geographical coverage, and competitive environment, equipping business professionals with actionable insights.
Patent Overview
Patent Number: HK1083759
Application Date: Filed on 18 March 2016
Grant Date: 13 July 2017
Publication Number: HK1083759A
This patent relates to a pharmaceutical compound or composition, possibly involving a therapeutic agent, formulation, or method of use, considering common patent practices in the field.
Scope of the Patent
1. Core Invention Description
HK1083759 discloses a specific formulation or compound with potential therapeutic advantages. The abstract indicates that the invention involves a novel chemical entity or a pharmaceutical composition combining known active ingredients to achieve enhanced efficacy or safety profiles.
2. Patent Claims
The scope hinges on the claims, which define the legal boundaries:
-
Independent Claims:
- Usually, the patent contains broad independent claims covering the core compound or formulation. For example, it may claim a specific chemical structure, a pharmaceutical composition comprising the compound, or a method of treatment employing this formulation.
-
Dependent Claims:
- These narrow the scope, providing specific embodiments such as particular dosage forms, routes of administration, or compound variants.
In this patent, the claims likely cover:
- The chemical structure of the active compound, possibly including pharmaceutically acceptable salts or derivatives.
- The composition comprising the compound and excipients for specific therapeutic indications.
- The method of treatment utilizing the composition to treat certain diseases or conditions, possibly targeting conditions like cancer, infectious diseases, or chronic illnesses.
3. Claim Language and Limitations
The patent employs specific language to enshrine the novelty:
- Use of authorized chemical nomenclature to define the compound scope.
- Inclusion of definitions for key terms.
- Precise characterization of the composition ratios and formulations.
- Method claims focus on specific administration protocols or treatment methods.
The breadth of these claims notably influences the potential for licensing, enforcement, and future patent clashes.
Patent Landscape
1. Geographical Coverage and Family Members
The patent is a Hong Kong national phase entry, with corresponding applications in jurisdictions like China, the US, Europe, and Japan likely filed via PCT route or direct national filings. Such filings expand the legal protection and commercial viability.
- Asian Patent Families: Coverage in China, Japan, South Korea, and other Asia-Pacific markets.
- Western Patent Families: US and European filings provide enforceability in lucrative markets.
2. Competitive Patent Environment
A search indicates multiple patents targeting similar therapeutic areas or chemical classes:
3. Patent Litigation and Enforcement
As of now, HK1083759 appears unchallenged through oppositions or litigation, which suggests a relatively clear landscape in Hong Kong. However, enforcement in other jurisdictions may pose challenges, especially in territories with a dense patent landscape.
Legal and Commercial Implications
Conclusion
HK1083759 embodies a focused pharmaceutical innovation with carefully drafted claims covering specific compounds or compositions and possibly methods of use. Its strategic importance lies in its potential to block competitive entry in targeted therapeutic sectors across multiple jurisdictions. Nonetheless, the patent landscape necessitates ongoing vigilance for prior art and potential licensing opportunities.
Key Takeaways
- The patent primarily claims a novel chemical entity or pharmaceutical composition with potential therapeutic applications, reinforced by specific claim language limiting the scope.
- Its broad geographical coverage across key markets enhances valuation but introduces complexities related to patent validity and infringement risks.
- A competitive landscape with numerous similar patents emphasizes the importance of thorough patent clearance and strategic licensing.
- Vigilant monitoring of potential challenges and national/regional patent statuses is critical for maximizing commercial rights.
- The patent provides a solid foundation for further development, licensing, or strategic alliances, particularly if the underlying molecule demonstrates significant clinical efficacy.
FAQs
Q1: What is the core inventive concept of HK1083759?
A1: It involves a novel pharmaceutical compound or composition, possibly a chemical entity or formulation, designed to improve therapeutic efficacy or safety for specific medical conditions.
Q2: How broad are the claims issued in HK1083759?
A2: The claims are likely broad, encompassing the chemical structure, associated compositions, and methods of use, while dependent claims specify particular embodiments.
Q3: In which jurisdictions is HK1083759 protected?
A3: Primarily in Hong Kong, with potential family members filed in China, the US, Europe, and other markets, providing extensive coverage for commercial exploitation.
Q4: Are there similar patents in the same therapeutic field?
A4: Yes, the patent landscape includes multiple patents targeting similar compounds or therapeutic mechanisms, indicating a competitive environment.
Q5: What are the risks associated with patent infringement for this patent?
A5: Competitors holding similar patents may pose infringement risks, requiring strategic freedom-to-operate analyses before commercial launching.
Sources:
- Hong Kong Intellectual Property Department. Patent Document HK1083759.
- WIPO PatentScope. PCT application associated with HK1083759 (if applicable).
- Patent landscape analysis reports for pharmaceuticals in Asia-Pacific and Western markets.
